Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D002090:Butyrophenones; D002746:Chlorpromazine / Q000494:pharmacology*; D006168:Guinea Pigs; D006220:Haloperidol / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D010210:Papillary Muscles / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D013881:Thioridazine / Q000494:pharmacology*
D014150:Antipsychotic Agents; D002090:Butyrophenones; D010880:Piperidines; D006220:Haloperidol; C008522:metylperon; D013881:Thioridazine; D002746:Chlorpromazine